| A multi-center study on the reproducibility of drug-response assays in mammalian cell lines M Niepel, M Hafner, CE Mills, K Subramanian, EH Williams, M Chung, ... Cell systems 9 (1), 35-48. e5, 2019 | 135 | 2019 |
| Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor Verteporfin in preclinical glioblastoma models AM Barrette, H Ronk, T Joshi, Z Mussa, M Mehrotra, A Bouras, ... Neuro-oncology 24 (5), 694-707, 2022 | 63 | 2022 |
| A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens M Bouhaddou, AM Barrette, AD Stern, RJ Koch, MS DiStefano, EA Riesel, ... PLoS computational biology 14 (3), e1005985, 2018 | 63 | 2018 |
| Antiinflammatory Effects of Budesonide in Human Fetal Lung AM Barrette, JK Roberts, C Chapin, EA Egan, MR Segal, JA Oses-Prieto, ... American journal of respiratory cell and molecular biology 55 (5), 623-632, 2016 | 41 | 2016 |
| Validating Antibodies for Quantitative Western Blot Measurements with Microwestern Array RJ Koch, AM Barrette, AD Stern, B Hu, M Bouhaddou, EU Azeloglu, ... Scientific Reports 8 (1), 11329, 2018 | 28 | 2018 |
| Effects of advancing gestation and non-caucasian race on ductus arteriosus gene expression N Waleh, AM Barrette, JM Dagle, A Momany, C Jin, NK Hills, EL Shelton, ... The Journal of pediatrics 167 (5), 1033-1041. e2, 2015 | 25 | 2015 |
| Integrating transcriptomic data with mechanistic systems pharmacology models for virtual drug combination trials AM Barrette, M Bouhaddou, MR Birtwistle ACS chemical neuroscience 9 (1), 118-129, 2018 | 22 | 2018 |
| Expression of human carcinoembryonic antigen‐related cell adhesion molecule 6 and alveolar progenitor cells in normal and injured lungs of transgenic mice S Lin, AM Barrette, C Chapin, LW Gonzales, RF Gonzalez, LG Dobbs, ... Physiological reports 3 (12), e12657, 2015 | 11 | 2015 |
| Expression of carcinoembryonic cell adhesion molecule 6 and alveolar epithelial cell markers in lungs of human infants with chronic lung disease LW Gonzales, R Gonzalez, AM Barrette, P Wang, L Dobbs, PL Ballard Journal of Histochemistry & Cytochemistry 63 (12), 908-921, 2015 | 9 | 2015 |
| An Integrated Mechanistic Model of Pan-Cancer Driver Pathways Predicts Stochastic Proliferation and Death M Bouhaddou, AM Barrette, RJ Koch, MS DiStefano, EA Riesel, AD Stern, ... bioRxiv, 128801, 2017 | 8 | 2017 |
| BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS JW Park, AM Barrette, W Wang, S Grossauer, G Grant, K Lau, S Pitteri, ... Neuro-Oncology 23 (Suppl 1), i3, 2021 | 2 | 2021 |
| A multi-center study on factors influencing the reproducibility of in vitro drug-response studies M Niepel, M Hafner, EH Williams, M Chung, AM Barrette, AD Stern, B Hu, ... bioRxiv, 213553, 2017 | 2 | 2017 |
| LGG-05. GENERATION OF NOVEL MOUSE MODELS FOR BRAF V600E MUTANT GLIOMAGENESIS TO GAIN MECHANISTIC INSIGHTS INTO TUMOR FORMATION AND PROGRESSION CK Petritsch, AM Barrette, JW Park Neuro-Oncology 23 (Suppl 1), i32, 2021 | 1 | 2021 |
| EXTH-22. VERTEPORFIN TREATMENT INHIBITS GBM GROWTH AND MIGRATION AND INFORMS HIPPO/RTK CROSSTALK AM Barrette, J Tome-Garcia, N Zaware, MM Zhou, M Birtwistle, ... Neuro-Oncology 20 (Suppl 6), vi89, 2018 | 1 | 2018 |
| MODL-18. ESTABLISHMENT OF A NOVEL HUMANIZED PERIPHERAL BLOOD MONONUCLEAR CELL (HU-PBMC) MOUSE MODEL TO EVALUATE LYMPHOCYTE INVOLVEMENT IN GLIOBLASTOMA AND ITS TREATMENT K Deshpande, D Kwang, M Cadiente, J Delany, T Ahmed, B McDonald, ... Neuro-Oncology 25 (Suppl 5), v302, 2023 | | 2023 |
| EXTH-79. A NOVEL ANTI-GALECTIN-3 ANTIBODY THERAPEUTIC SYNERGIZES WITH TEMOZOLOMIDE IN PRECLINICAL MODELS TO DIMINISH TUMOR GROWTH, DECREASE MIGRATION, AND PROLONG SURVIVAL AM Barrette, K Deshpande, B McDonald, M Cadiente, X Wang, D Sun Neuro-Oncology 25 (Suppl 5), v242, 2023 | | 2023 |
| A NOVEL ANTI-GALECTIN-3 MONOCLONAL ANTIBODY THERAPEUTIC DIMINISHES MIGRATION AND SLOWS TUMOR GROWTH TO PROLONG SURVIVAL IN GLIOBLASTOMA AM Barrette, K Deshpande, M Cadiente, X Wang, D Sun NEURO-ONCOLOGY 24, 226-226, 2022 | | 2022 |
| A novel anti-Galectin-3 antibody therapeutic for the treatment of glioblastoma AM BARRETTE, K Deshpande, M Cadiente, A Bei, X Wang, T Mirabella, ... Cancer Research 82 (12_Supplement), 1146-1146, 2022 | | 2022 |
| Clinically relevant MAPK pathway inhibition reverses stem cell fate defects and sensitize BRAF mutant glioma to immune modulatory therapies CK Petritsch, S Grossauer, W Wang, AM Barrette, J Park Cancer Research 81 (13 Supplement), 3072-3072, 2021 | | 2021 |
| LGG-05. GENERATION OF NOVEL MOUSE MODELS FOR BRAF V600E MUTANT GLIOMAGENESIS TO GAIN MECHANISTIC INSIGHTS INTO TUMOR FORMATION AND PROGRESSION A Barrette, J Park Neuro-oncology 23 (Suppl 1), i32-i32, 2021 | | 2021 |
